Global biomarker market to reach $130.2b by 2029

Advancements in omics technologies are driving the sector’s growth.

The global biomarker market is projected to reach $130.2b by 2029 at a compound annual growth rate of 13.1%, according to BCC Research.

The sector’s expansion is attributable to the increasing prevalence of chronic and infectious diseases, heightening the demand for biomarkers in early detection, diagnosis, and ongoing monitoring.

Moreover, advancements in omics technologies, including genomics, proteomics, and metabolomics, alongside the development of advanced imaging techniques, are driving market growth.

“Biomarkers are crucial in personalised medicine, helping to tailor treatments to individual patients based on their genetic and molecular profiles, resulting in more effective and targeted therapies with fewer side effects,” the report said.